GlassScriptPhysician profile
Daniel D Charous
NPI 1326017336
$195,800.65
in general payments reported to CMS, 2019-2025
15 companies · $15K in 2025
The $15K reported for 2025 was more than what 98% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67K · 2020: $46K · 2021: $15K · 2022: $11K · 2023: $21K · 2024: $20K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $52K · Food and Beverage: $3,012 · Travel and Lodging: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $52,469.20 |
| Food and Beverage | $3,012.26 |
| Travel and Lodging | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $125,023.91 | 2019-2023 | |
| Aerin Medical INC. | $34,555.42 | 2019-2025 | |
| Acclarent, INC | $20,040.92 | 2019-2024 | Trudi Nav Cable, Acclarent Aera, Relieva Spinplus |
| Integra Lifesciences Corporation | $13,721.90 | 2024-2025 | Acclarent Aera, Inspira Air, Trudi Probe |
| Intersect Ent, INC. | $977.20 | 2019-2021 | |
| Karl Storz Endoscopy-America | $664.92 | 2019 | |
| Optinose US, INC. | $213.95 | 2019-2023 | |
| Preceptis Medical, INC. | $155.53 | 2020 | |
| Stryker Corporation | $150.59 | 2019-2023 | Entellus Medical Focess Sinuscope, Scopis Ent |
| Arrinex, INC. | $140.76 | 2019 | |
| Medtronic, INC. | $63.00 | 2024 | Propel |
| Genzyme Corporation | $51.33 | 2019-2025 | |
| Glaxosmithkline, LLC. | $15.11 | 2023 | Nucala |
| Allergan, INC. | $13.06 | 2021 | |
| Boston Scientific Corporation | $13.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Charous listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.